Navigation Links
New Data Published in The Lancet Show GSK's ROTARIX(R) Offers Protection Against the Most Common Circulating Rotavirus Types
Date:11/23/2007

Protection Sustained During the First Two Years of Life

PHILADELPHIA, Nov. 23 /PRNewswire-FirstCall/ -- New data from a large European clinical trial published today in The Lancet show ROTARIX(R), GlaxoSmithKline's (NYSE: GSK) oral rotavirus candidate vaccine to prevent rotavirus gastroenteritis, provides protection against the five most commonly circulating rotavirus types around the world and in the United States (U.S.). The GSK candidate vaccine, if approved by the U.S. Food and Drug Administration (FDA), would enable completion of the rotavirus vaccination series by four months of age. Severe, dehydrating gastroenteritis occurs most commonly among children aged three to 35 months. Of children in the U.S. hospitalized with rotavirus, approximately one in five are younger than six months old.

Results from this multi-center, randomized, double-blind, placebo- controlled phase III clinical trial involving almost 4,000 European infants (candidate rotavirus vaccine n=2,572; placebo n=1,302) demonstrated that two doses of ROTARIX provided highly effective and sustained protection through two consecutive rotavirus seasons (approximately two years of age). The data show that, through two rotavirus seasons, the vaccine was highly efficacious against rotavirus hospitalizations (96%), severe rotavirus gastroenteritis (90%) and against rotavirus gastroenteritis of any severity (79%). Specifically, significant protection was demonstrated against severe rotavirus gastroenteritis caused by types G1 (96%), G2 (86%), G3 (94%), G4 (95%), and G9 (85%), the most commonly circulating rotavirus types around the world and in the United States.

"The candidate vaccine contains a live, weakened form of natural huma
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
6. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
7. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. Tumor Eradication Article Published by Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)...  Boston Scientific Corporation (NYSE: BSX ) ... Healthcare Conference on March 10 in Miami ... executive vice president and chief financial officer, and ... in a 25-minute question and answer session regarding the ... ET. Following a 5-minute break, a question and answer ...
(Date:2/27/2015)... , Feb. 27, 2015 /CNW/ - Covalon Technologies Ltd. (the ... company, today announced financial results for its first quarter ... three months ended December 31, 2014, revenue was $1,336,685. ... was $229,820 or $0.02 per share.  ... "I am very pleased with the significant progress we ...
(Date:2/27/2015)... 27, 2015  Uroplasty, Inc. (NASDAQ: UPI ), ... innovative proprietary products to treat voiding dysfunctions, today announced ... Conference on Tuesday, March 10, 2015. Rob Kill ... Chief Financial Officer, will present at 4:00 p.m. Pacific ... the conference at the Ritz Carlton in ...
Breaking Medicine Technology:Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Uroplasty to Participate in the 27th Annual ROTH Conference 2
... , ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity 2Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity 3Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity 4Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity 5Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity 6Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010 2Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010 3Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010 4Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010 5Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010 6Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010 7
(Date:2/28/2015)... Flagstaff, AZ (PRWEB) February 28, 2015 ... drug and alcohol treatment center , and current student ... State University, has implemented a weekly forum in psychoeducation ... high school in Flagstaff, AZ as part of her ... a big need for support and counseling at the ...
(Date:2/28/2015)... Toronto, ON (PRWEB) February 28, 2015 ... the Art of Facial Surgery was recently featured in ... 82 of the magazine, Dr. David Ellis was featured ... He discussed the various cosmetic enhancements that Kim Cattrall ... skin. , “Her forehead is smooth without horizontal ...
(Date:2/28/2015)... Plugin creators from Pixel Film Studios ... fully customizable transition pack made specifically for ... users total control over 30 transition presets built exclusively ... Film Studios. “TransFold Volume 2 gives endless possibilities to ... 2 from Pixel Film Studios brings back folding screen ...
(Date:2/28/2015)... February 28, 2015 1Heart Caregiver ... showcased emerging brand at Houston Texas Franchise Expo ... Vegas sending its executive delegates headed by Vice-President ... Development and Training Randolph Clarito. , Franchise Expo ... held last February 4-7 and featured Franchise brands ...
(Date:2/27/2015)... 27, 2015 A new study published ... between men who cycle on a regular basis and prostate ... study suggests that the more hours per week a man ... cancer, leading to an increased importance on prostate cancer screening ... to look more closely at patents’ risk factors for developing ...
Breaking Medicine News(10 mins):Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:Dr. David Ellis Featured In Elevate Magazine 2Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 3
... of treating devastating neurodegenerative disorders such as Huntington,s disease ... thanks to the use of cutting-edge genetic techniques. ... University of Lisbon (led by Dr Tiago Outeiro) and ... Paul Muchowski) collaborated to generate novel approaches for tackling ...
... January 10, 2011 -- While most blood tests require shipping a ... days for the results, a new device invented by a team ... just a pinprick of blood in a portable device that provides ... big step in point-of-care diagnostics, where testing can be performed in ...
... , FRIDAY, Jan. 7 (HealthDay News) -- U.S. government officials ... drinking water should now be set at the lowest recommended ... cavities and tooth decay, too much of it can cause ... teens have white spots and streaks on their teeth due ...
... Jan. 7 (HealthDay News) -- When you think of facial aging, ... that skin isn,t the only thing that ages. Over time, ... you look even older. And if crow,s feet and jowly ... the brow bone recedes and the jawbone becomes less defined. ...
... Just 5 percent of Parkinson,s disease cases can be explained ... But a new discovery by researchers at The University of ... why the vast majority of Parkinson,s patients develop the progressive ... Neuroscience , the researchers demystified a process that leads to ...
... BOSTON, Mass.Consumers may place a high value on information to ... out of pocket to get it. In a national survey ... people indicated that they would take a hypothetical predictive test ... breast or prostate cancer, or arthritis. On average, respondents were ...
Cached Medicine News:Health News:New hope in fight against Huntington's disease 2Health News:Engineering team invents lab-on-a-chip for fast, inexpensive blood tests 2Health News:U.S. Officials Recommend Reduced Fluoride Levels in Water 2Health News:Age Takes Toll on Facial Bones, Study Finds 2Health News:Age Takes Toll on Facial Bones, Study Finds 3Health News:Scientists shed light on what causes brain cell death in Parkinson's patients 2Health News:Most consumers want predictive tests to learn if a disease is in their future 2Health News:Most consumers want predictive tests to learn if a disease is in their future 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: